Osteoclast-activating factor (OAF) is a soluble mediator found in supernates of human peripheral leukocytes which have been cultured with antigens or phytomitogens. OAF is a potent stimulator of osteoclastic resorption of fetal bone in organ culture. The present studies were designed to characterize OAF chemically. Bone resorbing activity from supernates of leukocytes cultured without added plasma was not lost on dialysis using a membrane with a molecular weight cutoff of 3,500, but was lost when heated to 60°C for 30 min. The activity was lost after treatment with trypsin or pronase but not after treatment with ribonuclease or neuraminidase. Papain, which inactivated parathyroid hormone at a concentration of 25 µg/ml, did not inactivate OAF at 250 µg/ml. OAF did not react with an antibody to bovine parathyroid hormone which cross-reacts with human parathyroid hormone. OAF was also distinguished from active metabolites of vitamin D and from prostaglandin by extraction procedures and immunoassay for prostaglandin E 2 .
A B S T R A C T Osteoclast-activating factor (OAF) is a soluble mediator found in supernates of human peripheral leukocytes which have been cultured with antigens or phytomitogens. OAF is a potent stimulator of osteoclastic resorption of fetal bone in organ culture. The present studies were designed to characterize OAF chemically. Bone resorbing activity from supernates of leukocytes cultured without added plasma was not lost on dialysis using a membrane with a molecular weight cutoff of 3,500, but was lost when heated to 60'C for 30 min. The activity was lost after treatment with trypsin or pronase but not after treatment with ribonuclease or neuraminidase. Papain, which inactivated parathyroid hormone at a concentration of 25 /Lg/ml, did not inactivate OAF at 250 Ig/ml. OAF did not react with an antibody to bovine parathyroid hormone which crossreacts with human parathyroid hormone. OAF was also distinguished from active metabolites of vitamin D and from prostaglandin by extraction procedures and immunoassay for prostaglandin E2. When the medium from activated leukocytes cultured with autologous plasma was fractionated by gel filtration on Sephadex, bone resorbing activity eluted both with plasma proteins and in lower molecular weight fractions. However, when medium from leukocytes cultured without added plasma was chromatographed, all the OAF activity was eluted in a sharp low molecular weight peak located between chymotrypsinogen (25,000 molecular weight) and ribonuclease A (13,700 molecular weight). This peak contained about 4% of the total protein originally present in the supernate. Its activity was destroyed by overnight incubation at 370C at pH 6 or 8, but not at pH 7.2 . After incubation at 4VC, the activity was lost at pH 3 or 10, but not at pH 4-9. Received for publication 1 /Ag/ml). The medium was usually harvested at 24 and 72 h.
Pooled culture medium was sterilized by millipore filtration, concentrated 10-to 20-fold by ultrafiltration using Amicon PM10 membranes (Amicon Corp., Lexington, Mass.), and stored frozen at -20'C. Concentrated media were diluted with fresh BGJ before assay, or used directly for enzyme studies or chromatography.
Bone resorption assays. The method for measuring bone resorption in organ culture has been described previously (3) . Rats were injected with 0.4 mCi of 'CaCl2 on the 18th day of gestation. On the 19th day, the fetuses were removed and the shafts of the radius and ulna dissected and cultured in BGJ with 1 mg/ml bovine serum albumin or 5%o human plasma (both heat inactivated at 60'C for 30 min). After a 24-to 48-h period of preculture in control medium, which served to remove much of the exchangeable 'MCa, the bones were transferred to test or control media for assay. The test media consisted of appropriate dilutions of leukocyte culture medium or one of the materials described below. Control values for 4'Ca release were obtained by culturing bones in BGJ medium containing 1 mg/ml heat-inactivated bovine serum albumin or 5%o heatinactivated human plasma (for enzyme studies). After 2-4 days in culture, "Ca release from bones in the test medium was compared to 'Ca release in control cultures. When paired radii or ulnae from the same fetus were used, a treated-to-control ratio was calculated. In most experiments, treated bones were not paired with controls from the same fetus. Instead, a group of bones from each litter were used as controls, and the remaining bones were divided among the treatment groups. In these experiments, the percentage release of total PiCa was determined by Medium from PHA-stimulated leukocyte cultures without added plasma wag treated as indicated, then diluted with fresh medium and assayed for bone-resorbing activity. Experiment A: dialysis against BGJ, using Fisher dialyzer tubing (Fisher Scientific Co., Pittsburgh, Pa.), nominal molecular weight cutoff about 12,000. Experiment B: dialysis against BGJ using Spectrapor 3 dialysis membranes (see Methods), nominal molecular weight cutoff about 3,500. Experiment C: samples concentrated to one-fourth the original volume using Amicon filters PM 10 or XM5O. Retentates were diluted back to the original volume with BGJ for assay, while filtrates were assayed directly. PM 10 and XM5O membranes have nominal molecular weight cutoffs of 10,000 and 50,000, respectively. measuring radioactivity in both bone and medium and was calculated as follows: percent release= (medium dpm/
[medium dpm + bone dpm]) X 100.
Enzyme digestion. Trypsin (lyophilized, salt-free 1 X crystallized, 150 U/mg protein) was obtained from Worthington Biochemical Corp., Freehold, N. J. Enzymes, obtained from Sigma Chemical Co., St. Louis, Mo., were papain (2 X crystallized, 30 U/mg protein), pronase (protease type VI, 3 U/mg protein), ribonuclease (5 X crystallized type I-A, 75 Kunitz U/mg protein), and neuraminidase (type V, 12 U/,gg solid, using bovine submaxillary mucin as substrate). The effects of incubation with enzymes were tested on samples of 10 X concentrated leukocyte supernate and purified bovine parathyroid hormone (kindly provided by Dr. W. Y. W. Au). The samples were exposed to enzymes in BGJ without added albumin or plasma at 370C for 1 h under an atmosphere of 5% CO2 in air, pH approximately 7.3-7.4. After incubation, the samples were diluted 10-fold with BGJ containing 5% heat-inactivated human plasma. The final concentrations of enzymes were those which, in preliminary experiments, had been shown to have no effect on control resorption, and additional control cultures with enzyme were used in each experiment to confirm this. Enzymes which did not destroy OAF activity were assayed by using standard substrates after incubation in BGJ for 1 h at 370C in 5% CO2. Bovine submaxillary mucin (Sigma Chemical Co.) was used as substrate for neuraminidase, Escherichia coli RNA (Calbiochenm, San Diego, Calif.) for ribonuclease, and a-N-benzoyl-L-arginine ethyl ester (Sigma Chemical Co.) for papain. Under these conditions, neuraminidase retained 15%, ribonuclease 70%, and papain 19%o of their originally specified specific activities toward these substrates.
Extraction procedures. Concentrated leukocyte culture media were extracted with solvents which are known to remove the potent lipid soluble bone resorbing agents, 1,25-(OH)2D3 (4, 5) , and PGE2 (6, 7) from biological samples. OAF samples, control medium, and medium to which authentic 1,25-(OH) 2Ds or PGEs had been added were prepared and extracted either with chloroform-methanol (1: 1) followed by chloroform (for vitamin D metabolites), or with redistilled ethyl acetate after adjustment of the medium to pH 3.5 with glacial acetic acid (for PGE2). Extraction was repeated three times, and the organic phases were pooled and dried under nitrogen, and the residue was dissolved with BGJ for assay.
Gel filtration chromatography. All chromatographicsteps were-carried out at 4°C. 2-3 ml of concentrated leukocyte supernates was applied to columns of Sephadex G-150 or G-100 equilibrated in 0.02 M sodium phosphate buffer with 0.15 M NaCl, pH 7.2, and eluted with buffer. The fractions were pooled and dialyzed against BGJ at a phosphate concentration adjusted to produce a final concentration of 1.0 mM. The dialysis membrane used was boiled Spectrapor 3 (Spectrum Medical Industries, Inc., Los Angeles, Calif.), with a nominal molecular weight cutoff of 3,500. Dialyzed fractions were further diluted with fresh BGJ for assay. Protein was determined by the method of Lowry, Rosebrough, Farr, and Randall (8) . The elution volumes of column fractions were used to calculate the partition coefficient (KD), both for OAF activity and for standard calibration proteins (Pharmacia Calibration Kit, Pharmacia Fine Chemicals, Inc., Piscataway, N. J.). KD was calculated as follows: KD = (V. -V.)/V1, where V. was the peak elution volume of the material in question, V. was the peak elution volume for blue dextran, and V; In experiments A and B, media containing OAF, 10 X concentrate, or PTH, 10 pg/ml, and control media were digested with enzymes added at the indicated concentration for 1 h at 371C, followed by 10-fold dilution with fresh medium before assay. In experiment C, bones were incubated for 1 day, with or without trypsin, washed with fresh medium, and placed in assay medium. Values are mean±SEM (four to eight bones per point).
* Significant difference from control (P < 0.05).
was the difference between the peak elution volumes of blue dextran and tritiated water under the operating conditions used. KD VS. log (molecular weight) gave a linear plot for the calibration proteins used (9 (Table I) . PHA alone had no effect on bone resorption. Leukocytes cultured without added serum showed as great a stimulation of thymidine uptake and released as much OAF as did leukocytes cultured with 20% autologous plasma. When OAF-containing media were dialyzed by using cellulose membranes with a nominal molecular weight cutoff of 12,000, much of the activity was lost (Table II) (Table  IV) . The bone-resorbing activity of 1,25-(OH)2D3 was extracted from BGJ medium with chloroform-methanol, while the activity of PGE2 was extracted with ethyl acetate after acidification (Table IV) . Neither extraction procedure yielded biological activity from supernates containing OAF. By immunoassay, the supernate with maximal OAF activity contained 0.5 ng/ml of bovine PTH equivalent. Much of this could be ascribed to nonspecific displacement of labeled hormone, since BGJ alone gave a value of 0.4 ng/ml. There was no detectable PGE2 by immunoassay in the ethyl acetate extracts under conditions which should have detected as little as 2 X 10' M PGE2 in the original medium.
Initial OAF samples obtained from leukocytes cultured in 20% autologous plasma showed widely dispersed activity when chromatographed on Sephadex G-150 (Fig. 1) . The greatest biological activity eluted in the albumin fraction, but activity was also found in lower molecular weight fractions. Fractions of supernates from inactive leukocyte cultures showed no bone-resorbing activity when compared with the same fractions from control media, which had been incubated without cells. When OAF was obtained from supernates of leukocytes cultured without added serum, there was no longer any detectable biological activity in the albumin region (Fig. 2) , and the activity now eluted as a discrete symmetrical peak on Sephadex G-100 after chymotrypsinogen (25,000 molecular weight) and before ribonuclease A (13,700 molecular weight). No bone-resorbing activity was found in any fraction of medium from unstimulated cultures (1% PHA added after culture). The OAF peak had a KD of 0.52. The active fractions from the G-100 column contained only about 4% as much protein as the original supernate (Table V) and showed a similar dose-response curve to crude OAF with no evidence of loss of activity on the column (Fig. 3) . When partially purified OAF from G-100 columns was incubated at 370C overnight at pH 6 or 8.1, activity was lost (Fig. 4) , but activity was not lost at pH 7.4. When incubated at 4VC overnight, the activity was completely lost only at pH 3 or 10, and significant activity was retained over a range of 4.0-8.5 (Fig. 4) . However, the maximal recovery appeared to be at neutral pH. Because of these results, further purification was attempted at pH 7.2 by using DEAE and CM cellulose. The activity was recovered in the initial buffer wash and not retarded on either column. There even appeared to be a slight increase in activity in the eluate from the CM cellulose column (Fig. 5) . Although OAF was not retained on DEAE or CM cellulose, some contaminants were apparently removed, since the protein content was reduced by about seven-fold without loss of biological activity. Attempts to purify OAF further on CM cellulose at pH 5.3 were unsuccessful. This was ascribed to inactivation, since no biological activity was found either in the column fractions or in the original sample after dialysis against pH 5.3 ammonium acetate buffer.
DISCUSSION
The studies reported here were designed to compare the chemical characteristics of OAF with those of other stimulators of bone resorption. The original studies (2) of bone-resorbing activity in supernates of activated leukocyte-cultures did not distinguish OAF from other agents known to cause bone resorption, such as PTH, active metabolites of vitamin D, or prostaglandins. The fact that OAF is heat labile and nondialyzable suggests that it is macromolecular, like PTH. However, OAF Enzyme inactivation studies indicated that OAF activity was dependent on a protein moiety. Failure to inactivate OAF with ribonuclease or neuraminidase indicates that nucleic acids are probably not an important component and that terminal sialic acid residues are either absent or not required for biologic activity. Chromatographic studies also indicated that OAF was a macromolecule, which was not highly charged on the basis of its behavior on ion exchange resins. When OAF was produced in cultures containing added plasma, the elution pattern on Sephadex G-100 was very disperse.
This may have been, the result of aggregation, binding to plasma proteins, or distortion of the elution pattern by the large amount of protein which had to be placed on the column to recover significant amounts of activity. Moreover, it is possible that OAF produced by lymphocytes in the presence of added autologous plasma is heterogeneous and that these different active fractions represent different biologically active molecules.
When OAF was produced by normal human leukocytes in the absence of added plasma, a single symmetrical peak of biological activity eluted from Sephadex G-100 with a KD of about 0.52. When compared to the elution for. globular proteins, this value would correspond to a mass of about 18,000 daltons. However, since we do not known whether OAF is a globular protein, this may not represent the true molecular weight. Sephadex-purified OAF was relatively stable at neutral pH, but rapidly inactivated at both high and low pH, particularly at 370C. Since these preparations were not pure, we cannot determine whether this is the result of activation of enzymes present in the fraction or direct inactivation of OAF. Further purification of OAF was attempted by using DEAE cellulose and CM cellulose columns at neutral pH. The biological activity was eluted with the buffer and not adsorbed to the resin. Nevertheless, some purification resulted because of the removal of contaminants, and the final product was biologically active * INCUBATION pH FIGURE 4 Effect of pH on OAF activity. Purified OAF from G-100 chromatography was adjusted (in column buffer) to the indicated pH values, stored overnight at 4VC or 37' C, then dialyzed against BGJ medium before assay of bone-resorbing activity. Values are mean ± SEM for four to eight pairs of bones per point. *, 4VC; 0, 37'C; *, significantly different from control (P < 0.05). (14) . Human mononuclear leukocyte chemotactic factor (15) , on the other hand, elutes from Sephadex G-100 coincident with cytochrome C (molecular weight 12,500). The peak activity for OAF is clearly and reproducibly (cf., Fig. 2 ) between the elution positions of chymotrypsinogen and ribonuclease A (molecular weight 13,700). In addition, both MIF and human mononuclear leukocyte chemotactic factor are heat stable, while OAF is heat labile. Human lymphotoxin (16), which is heat labile, is a considerably larger molecule than OAF, as evaluated by Sephadex G-100 chromatography. We cannot exclude the possibility, however, that OAF represents a variant form of some previously described lymphokine or that OAF has other activities in different biological assay systems than the one used in these studies. Purified guinea pig complement factor C'5a, which has chemotactic activity (17) , elutes from Sephadex G-100 at about the same position as OAF. However, preliminary experiments 2 failed to detect any bone-resorbing activity of either guinea pig or human C'5a.
The biological importance of OAF is not yet known. The production of such a potent stimulator of bone resorption by activated leukocytes in vitro suggests that activation of leukocytes in chronic inflammation might also lead to OAF secretion. If so, it could be responsible for some of the changes in bone resorption seen locally in periodontal disease, arthritis, or osteomyelitis. A factor such as OAF could also be important in neoplastic diseases, particularly those that involve proliferation of lymphoid cells which could themselves produce OAF. We have obtained evidence that lymphoid cell lines derived from patients with hematologic neoplasms produce an 'L. G. Raisz and R. Snyderman, unpublished results.
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FIGURE 5 Ion exchange purification of OAF. Samples of active fraction OAF from G-100 chromatography were dialyzed against 0.05 M Tris-HCl, pH 7.0, for DEAE cellulose purification, or against 0.02 M N-2-hydroxyethylpiperazine-N'-2-ethane sulfonic acid, pH 7.0, for CM cellulose purification. For both ion exchangers, the column (0.9 X 10 cm) was washed with starting buffer after applying the same, then eluted with a linear gradient of NaCl, 0,-0.5 M in starting buffer. The CM cellulose column was also washed with 1.0 M NaCl after elution. Fractions were dialyzed against BGJ, concentrated to the volume of the original sample, and assayed for bone-resorbing activity. Values are mean ±SEM for four pairs of bones per point. *, significantly different from control (P < 0.05).
OAF-like material (18) . OAF-like factors could aid the development of bone metastases or promote hypercalcemia in such diseases. Finally, it is possible that in other neoplasms the cellular immunity of the host could result in activation of lymphocytes which produce OAF and affect bone.
